NIH Hides Away to Judge Mental Health Grant Applications
Published Date: 1/14/2026
Notice
Summary
The Center for Scientific Review is holding two closed virtual meetings in February 2026 to review important grant applications related to mental health and small business medical research. These meetings keep sensitive info private to protect ideas and personal details. Scientists and small businesses applying for grants should note these dates as part of the funding review process.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Closed review for mental health grants
On February 5, 2026 from 2:00 p.m. to 6:00 p.m. (virtual), the NIH Center for Scientific Review will hold a closed meeting of the Psychopathology, Addictions and Sleep Disorders panel to review and evaluate grant applications. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information of applicants.
Closed review for small-business medical grants
On February 13, 2026 from 1:30 p.m. to 4:30 p.m. (virtual), the NIH Center for Scientific Review will hold a closed Special Emphasis Panel titled 'Small Business: Gastroenterology and Hepatology' to review and evaluate grant applications. The meeting is closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to prevent disclosure of confidential trade secrets, patentable material, and personal data of applicants.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2026-00546 — Office of the Director, National Institutes of Health; Notice of Meeting
The National Institutes of Health (NIH) is holding a virtual meeting on January 29, 2026, to discuss a plan to reorganize part of their office by creating two new teams focused on research innovation and economics. This affects researchers and the public, who can share their thoughts by January 26. The meeting also includes a private session to review grant applications, which could impact future funding decisions.
Next: 2026-00548 — National Human Genome Research Institute; Notice of Closed Meeting
The National Human Genome Research Institute is holding a private meeting on February 17, 2026, to review and evaluate the skills and work of its researchers. This closed meeting affects the scientists working there and helps ensure top-notch research quality. No public access or funding changes are involved, but it’s a key step in keeping the team sharp and effective.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in